Australia markets closed

Unity Biotechnology, Inc. (UBX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.4800-0.0200 (-1.33%)
At close: 04:00PM EDT
1.5197 +0.04 (+2.68%)
After hours: 06:59PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
19,803
12,736
32,905
17,807
Other short-term investments
23,398
82,059
55,170
79,892
Total cash
43,201
94,795
88,075
97,699
Other current assets
871
417
1,879
3,167
Total current assets
46,605
96,535
90,504
100,866
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
27,324
39,621
43,486
45,878
Accumulated depreciation
-9,261
-12,754
-12,258
-9,742
Net property, plant and equipment
18,063
26,867
31,228
36,136
Equity and other investments
-
0
1,993
17,871
Other long-term assets
1,022
948
987
1,446
Total non-current assets
19,085
27,815
34,208
55,453
Total assets
65,690
124,350
124,712
156,319
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
-
9,476
3,055
-
Accounts payable
1,380
1,790
1,985
2,558
Accrued liabilities
1,158
2,224
1,982
2,009
Deferred revenues
-
0
216
0
Other current liabilities
10
10
973
21
Total current liabilities
7,840
19,620
16,617
14,463
Non-current liabilities
Long-term debt
-
10,891
18,409
24,508
Other long-term liabilities
-
-
23
-
Total non-current liabilities
29,452
48,646
48,526
58,976
Total liabilities
37,292
68,266
65,143
73,439
Stockholders' equity
Common stock
2
1
1
5
Retained earnings
-484,353
-444,493
-400,024
-339,299
Accumulated other comprehensive income
-24
-251
-44
5
Total stockholders' equity
28,398
56,084
59,569
82,880
Total liabilities and stockholders' equity
65,690
124,350
124,712
156,319